Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Seeks Part D Prior Authorization Criteria Transparency In 2009

Executive Summary

CMS is aiming to make Medicare Part D formulary prior authorization practices more clear and consistent by proposing new requirements for drug plans in its draft "call letter" to prospective plan sponsors for the 2009 benefit year
Advertisement

Related Content

Medicare Plans’ Formulary Restrictions Will Get More Scrutiny In 2010 Bids – CMS
Medicare Bill Allows Changes To Part D Protected Classes, Via Rule-Making
Medicare Bill Allows Changes To Part D Protected Classes, Via Rule-Making
Commercial Health Plans Following Part D Lead With 4-Tier Formularies
Commercial Health Plans Following Part D Lead With 4-Tier Formularies
2009 Part D plan instructions
2009 Part D plan instructions
Medicare Gap Coverage For Generics Offered By 12 National Sponsors In 2008
Medicare Gap Coverage For Generics Offered By 12 National Sponsors In 2008
Advertisement
UsernamePublicRestriction

Register

PS049226

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel